SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029304
Filing Date
2018-11-13
Accepted
2018-11-13 16:06:54
Documents
48
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-10q_20180930.htm 10-Q 949500
2 EX-31.1 crnx-ex311_6.htm EX-31.1 21233
3 EX-31.2 crnx-ex312_8.htm EX-31.2 21186
4 EX-32.1 crnx-ex321_7.htm EX-32.1 7058
  Complete submission text file 0001564590-18-029304.txt   3655056

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crnx-20180930.xml EX-101.INS 685136
6 XBRL TAXONOMY EXTENSION SCHEMA crnx-20180930.xsd EX-101.SCH 31548
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crnx-20180930_cal.xml EX-101.CAL 34245
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crnx-20180930_def.xml EX-101.DEF 85745
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20180930_lab.xml EX-101.LAB 271926
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20180930_pre.xml EX-101.PRE 193865
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 181177968
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1